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Abstract Overall cancer incidence has been observed to be
lower in Mediterranean countries compared to that in
Northern countries, such as the UK, and the USA. There is
increasing evidence that adherence to a Mediterranean dietary
pattern correlates with reduced risk of several cancer types and
cancer mortality. In addition, specific aspects of the
Mediterranean diet, such as high consumption of fruit and
vegetables, whole grains, and low processed meat intake, are
inversely associated with risk of tumor pathogenesis at differ-
ent cancer sites. The purpose of this review is to summarize
the available evidence regarding the association between the
Mediterranean diet and cancer risk from clinical trials, pro-
spective cohort studies, and case–control studies.
Furthermore, we focused on the different definitions of a
Mediterranean diet in an attempt to assess their efficiency.
Observational studies provide new evidence suggesting that
high adherence to a Mediterranean diet is associated with re-
duced risk of overall cancer mortality as well as a reduced risk
of incidence of several cancer types (especially cancers of the
colorectum, aerodigestive tract, breast, stomach, pancreas,
prostate, liver, and head and neck).
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Introduction
In 2013, the number of deaths worldwide and throughout all
age groups reached nearly 55 million, with 70 % of them
caused by non-communicable diseases, including 15 %
caused by cancer [1]. In spite of a decrease in death due to
neoplastic disease since 1990, cancer remains a tremendous
health problem. According to estimations by the International
Agency for Research on Cancer, the 5-year global cancer
prevalence is ∼28.8 million in 2008. With respect to localiza-
tion, the most prevalent cancer worldwide continues to be
carcinoma of the breast. Prostate cancer is the most common
neoplastic disease in the USA and Oceania as well as Western
and Northern Europe [2].
For several decades now, observational studies point out
that the incidence of overall cancer is lower in countries bor-
dering the Mediterranean Sea when compared to that in
Northern countries, the UK, and the USA [3]. The concept
of a BMediterranean diet^ (MD) was developed to reflect the
typical dietary habits adopted during the early 1960s by in-
habitants of theMediterranean basin, mainly in Crete, much of
the rest of Greece, and Southern Italy [4]. Adherence to a MD
has previously been reported to be effective in the primary and
secondary prevention of a number of chronic non-
communicable diseases, such as cardiovascular diseases [5•],
neurodegenerative diseases [6], type 2 diabetes mellitus [7],
and neoplastic diseases [8, 9].
In 2014, we published a meta-analysis of observational
studies investigating the effects of conformity with an MD
on overall cancer risk (incidence and mortality) and risk of
development of different types of cancer [10••]. Our findings
further underlined the importance of a MD as a potential
health-promoting dietary pattern, and it became reasonable
to update this systematic review only a year later due to the
large number of additional observational studies (14 cohort
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and 9 case–control studies) published in the interim brief pe-
riod [11••]. In both meta-analyses, adherence to the highest
category of MD was associated with a significant reduction in
the risk of overall cancer mortality/incidence as well as the
incidence of several cancer types (especially cancers of the
colorectum, aerodigestive tract, breast, stomach, pancreas,
prostate, liver, and head and neck).
The number of cancer survivors in the USA and Europe is
rapidly growing [12, 13]. A few prospective cohort studies
investigated the association between composition of the diet
and cancer survival, reporting inconsistent results [14•]. For
example, several studies focused on the evaluation of the re-
lationship between survival and nutrients rather than dietary
patterns [14•, 15]. The objective of the current review was to
summarize the available evidence on Mediterranean diet and
cancer risk (with respect to incidence, survival, and mortality)
as well as to report on current results and futures directions.
Prior to that, we provide an overview of the most common
ways to define a Mediterranean diet.
What is a Mediterranean Diet?
The most commonly used operational definition of a MD is
the Mediterranean Dietary score proposed by Trichopoulou
et al. in 1995 [16], which was updated in 2003 [17]. The
Mediterranean score is built by assigning a value of 0 or 1 to
each of nine components with the use of sex-specific medians
as the respective cutoffs. In detail, this MD score is character-
ized [17] by six beneficial components (high consumption of
vegetables, fruits and nuts, legumes, unprocessed cereals, fish,
and a high ratio of monounsaturated fatty acids to saturated
fatty acids) and two components regarded to be detrimental
(meat and meat products including poultry and dairy products
with the exception of cheeses preservable for a long period of
time). With respect to favorable ingredients, persons whose
consumption is at or above the median receive a score of 1 for
each category, and persons whose consumption is below the
median receive a score of 0. With respect to unfavorable in-
gredients, the scoring system is applied with reversed signifi-
cation. The potential benefit of moderate alcohol consumption
is taken into account by assigning a value of 1 to men who
consume between 10 and 50 g per day and to women who
consume between 5 and 25 g per day, respectively [17]. The
highest adherence to a MD is therefore represented by a max-
imum score of 9.
The second most widely used MD score is an alteration of
the original score by Trichopoulou adapted by Fung et al. in
2006 [18]. The following components were either excluded or
modified: exclusion of potato products from the vegetable
group, separation of fruits and nuts into two groups, exclusion
of the dairy group, inclusion of whole-grain products only,
inclusion of red and processed meats only in the meat group,
and assignment of 1 point for alcohol intake between 5 and
15 g/day. In 2014, Whalen et al. [19] modified this alternate
MD score with respect to dairy foods, grains and starches, and
alcohol intakes. Another variation of the score by
Trichopoulou et al. [17] was introduced by Tognon et al.
[20] and Xie et al. [21] by adding fruit juices and polyunsat-
urated fatty acids, focusing on whole grains, and excluding
poultry. The MD score established by Panagiotakos et al. in
2007 [22, 23] is based on 11 main components (non-refined
cereals, fruits, vegetables, potatoes, legumes, olive oil, fish,
red meat, poultry, full-fat dairy products, and alcohol).
Consumption of items adhering to this pattern will result in
scores of 0, 1, 2, 3, 4, and 5 when a participant reported no,
rare, frequent, very frequent, weekly, and daily consumption,
respectively. Three of the 11 components were considered to
exert detrimental effects (red meat, poultry, full-fat dairy prod-
ucts). For alcohol, a value of 5 is assigned to subjects who
consume <300 ml (12 g ethanol) alcoholic beverages per day,
and a value of 0 is applied if alcohol consumption is either
>700 or 0 ml/day.
Other infrequently used MD scores include the
Mediterranean Diet quality index [24], the Mediterranean
Score by Goulet et al. [25], the Mediterranean Diet pattern
score [26], the Mediterranean dietary pattern adherence index
[27], and the Mediterranean Adequacy Index [28].
Mediterranean Diet and Cancer Risk
Overall Cancer Mortality
RCTs
The first clinical trial to demonstrate the protective effects of
the MD in the secondary prevention of ischemic heart disease
was the Lyon Diet Heart study. Participants were asked to
replace butter and cream with a special alpha-linolenic-acid-
rich margarine. Apart from cardiovascular diseases, protective
effects of an MD were also reported with respect to the risk of
cancer development [29]. Results of the study were transferred
into the following food advices: to increase the consumption
of vegetables, fruits, and fish, but to reduce the consumption
of red meats.
Besides the Lyon Diet Heart study, there is only one other
randomized controlled trial of a Mediterranean diet reporting
on cancer risk. The BPrevención con Dieta Mediterránea^
(PREDIMED) trial focused on the intake of extra virgin olive
oil (50 g/day) and nuts (30 g/day) in the intervention groups
[30••]. Results including 7447 subjects showed that the
highest category of nut intake (>3 servings/week) was associ-
ated with a 40 % risk reduction of cancer mortality when
compared to the lowest category [31•], whereas the
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differences observed between consumption categories of extra
virgin olive oil did not attain statistical significance [32•].
Prospective Cohort Studies
Overall risk of cancer mortality was evaluated in 11 cohort
studies (European Prospective Investigation into Cancer and
Nutrition (EPIC), Nurses’ Health Study, Health Professionals
Follow-up Study, Aerobics Center Longitudinal Study,
Women’s Health Initiative Observational Study, Multiethnic
Cohort, HALE and SENECA study, SUN-cohort, Seven
Countries Study, National Institutes of Health American
Association of Retired Persons (NIH-AARP), Västerbotten
Intervention Program-cohort, Swiss National Research
Program 1A, MONICA) [20, 33–42]. Six of these cohorts
did not show a significant correlation between adherence to
anMD and cancer risk. However, pooling all 11 cohort studies
in a meta-analysis yielded a 13 % risk reduction of overall
cancer mortality when comparing the highest versus lowest
adherence to MD categories [11••].
Cancer Localizations
Breast Cancer
Five prospective cohort studies [18, 20, 43–45] and eight
case–control studies [46–53] investigated the effects of con-
formity to an MD and risk of breast cancer. Pooling eight
case–control studies resulted in a 10 % reduction of breast
cancer incidence. However, pooling cohort studies (which
are characterized by a higher level of evidence) did not con-
firm these results, i.e., none of the prospective cohort studies
showed a significant inverse association between concordance
to MD and breast cancer risk. Furthermore, we detected a
trend for an association between high adherence to MD and
reduced risk of breast cancer in postmenopausal women.
Differentiating breast cancer types as classified by receptor
status yielded significant results when comparing the highest
versus lowest adherence category to MD only for the ER−/
PR+ type (relative risk (RR) 0.71, 95 % confidence interval
(CI) 0.56 to 0.89) [11••].
Colorectal Cancer
Four prospective cohort studies [20, 54–56] and four case–
control studies [19, 57–59] investigated the effects of adher-
ence to MD and risk of colorectal cancer. Of these eight stud-
ies, two cohort and three case–control studies demonstrated a
significant inverse association between adherence to MD and
incidence of colorectal cancer. Following synthesis of all re-
sults via meta-analysis (excluding the study Tognon et al.
2012 on colorectal cancer mortality), a 17 % risk reduction
for colorectal cancer could be detected when juxtaposing the
highest versus lowest MD categories [11••].
Prostate Cancer
The risk of prostate cancer could be reduced by 4 % compar-
ing the highest versus lowest adherence to MD category in-
cluding four cohort studies [20, 60–62] and one case–control
study [63].
Gastric Cancer
The EPIC study demonstrated a 33 % reduced risk of gastric
adenocarcinoma following comparison of the third versus the
first tertile of conformity to an MD [64]. Pooling all available
cohort [64, 65•] and case–control [66] studies revealed a 27%
reduced risk of gastric cancer incidence [10••].
Liver Cancer
To date, only two studies (one cohort [67] and one case–con-
trol study [68]) investigated the effects of MD adherence on
liver cancer risk. Both studies observed a significant inverse
association (42 % reduced risk) [11••]
Esophageal Cancer
The NIH-AARP-cohort study including nearly 500,000 sub-
jects showed a significant risk reduction for esophageal squa-
mous cell carcinoma (RR 0.44, 95 % CI 0.22 to 0.88), but not
for esophageal adenocarcinoma [65•] in individuals adopting
a MD pattern. An Italian case–control study reported a lower
odds ratio for esophageal cancer in participants with high ad-
herence to MD [69].
Head and Neck Cancer
Pooling one cohort study [70] and three case–control studies
[69, 71, 72] in a meta-analysis resulted in a significantly re-
duced risk of head and neck cancer incidence (RR 0.40, 95 %
CI 0.24 to 0.66) when comparing the highest versus the lowest
categories of MD adherence. However, the data turned out to
be non-significant in a sensitivity analysis considering only
data from cohort studies [11••].
Pancreatic Cancer
Both a Swedish cohort study (pancreatic cancer mortality)
[20] and an Italian case–control study [73] reported a signifi-
cant inverse association between the highest concordance cat-
egory to MD and pancreatic cancer risk. However, pooling
these two studies resulted in a non-significant risk reduction,
probably due to high between-study heterogeneity.
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Ovarian, Bladder, and Endometrial Cancer
No significant associat ion between adherence to
Mediterranean diet and risk of ovarian cancer could be ob-
served in the Nurses’ Health Study [21]. Including 477,312
subjects from the EPIC study indicated a negative association
between adherence to a MD pattern and risk of bladder cancer
that was, however, non-significant [74]. Among postmeno-
pausal women in the Women’s Health Initiative Clinical
Trial and Observational Study, high conformity to MD (fifth
vs. first quintile) was not significantly associated with risk of
endometrial cancer [75]. In contrast, data from three case–
control studies showed that high adherence (six to nine com-
ponents) to MD correlated with a reduced odds ratio (OR
0.43) for endometrial cancer incidence [76], while a fourth
case–control study from the USA did not confirm these pro-
tective effects of a MD [77].
Respiratory Tract Cancer
Two cohort studies investigated the effects of adherence to
MD and risk of respiratory tract cancer [20, 78]. Pooling their
data yielded a non-significant correlation between MD and
reduction of respiratory tract cancer incidence [11••].
Mediterranean Dietary Pattern and Cancer
Survivors/Recurrence
The potential correlation between conformity to a high MD
score and cancer mortality among cancer survivors was eval-
uated in three cohort studies [62, 79•, 80] while cancer recur-
rence among cancer survivors was assessed in one cohort
study [81]. No significant association betweenMD and cancer
mortality or cancer recurrence could be observed.
Diet Among Cancer Survivors
Tumor progression and recurrence as well as survival of can-
cer patients were shown to be affected by aspects of nutrition
such as macronutrient composition or supplementation with
specific nutrients, and some of these research studies have
been transferred into recommendations and guidelines for
cancer survivors [13, 14•]. Moreover, there are some studies
dealing with the effects of food groups in cancer patients. A
diet emphasizing fruits and vegetables, whole grains, and fish,
but low amounts of red or processed meat and sugars, was
associated with decreased mortality rates in cancer survivors
[82–84]. Taken together, this description fits well with the
characteristics of a Mediterranean diet. In the last part of this
review, wewill take a closer look at some of these components
and their potential interactions with cancer development and
progression focusing on data provided by systematic reviews
and meta-analyses.
Components of Mediterranean Diet and Cancer
Fruit and Vegetables
A protective effect of fruits and vegetables on cancer initiation
and progression might be explained by their high content of
flavonoids exerting favorable biological effects such as anti-
oxidant, anti-inflammatory, anti-mutagenic, or anti-
proliferative properties [85]. Prospective cohort studies
yielded inconsistent results regarding fruit and vegetable in-
take and cancer risk. Data from the EPIC cohorts provide
evidence of at least a weak inverse association between high
consumers and lower risk [86, 87]. However, these findings
are not uniform as shown, e.g., by George et al. [88] following
analysis of data from the cohort of the National Institutes of
Health-AARP Diet and Health Study. In a recent meta-
analysis synthesizing data from 16 prospective cohort studies,
a higher consumption of fruit and vegetables did correlate
with a decrease in all-cause mortality, albeit not with a signif-
icant reduction in cancer-related death [85].
Fish
A higher consumption of fish is recommended especially due
to its content of n-3 fatty acids. Via their anti-inflammatory
effects, n-3 may suppress carcinogenesis and act in a protec-
tive manner against tumor initiation and progression.
However, recent meta-analyses show rather inconsistent and
inconclusive results with respect to inverse relationships be-
tween uptake of marine n-3 fatty acids or fish consumption
and cancer incidence/mortality [89•, 90].
Whole Grain
Increased uptake of dietary fiber is regarded to be protective
especially against the development of colorectal cancer, e.g.,
via an enlargement of the bulk of stool leading to a concom-
itant reduction in transit time thereby diminishing the impact
of potential carcinogenic substances on the colonic epitheli-
um. In addition, metabolization of fiber to short-chain fatty
acids by intestinal bacteria may prevent dedifferentiation of
colonic cells and support defense mechanisms against initiat-
ed cells by apoptosis [91]. In fact, there are a number of data
from observational studies consistent with this hypothesis.
Thus, consumption of whole grains and dietary fiber was in-
versely associated with risk of developing colorectal cancer in
meta-analyses by Haas et al. [92] as well as Aune et al. [93].
Moreover, intervention and observational studies showed that
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dietary fiber is associated with reduced risk of insulin resis-
tance [94, 95].
Olive Oil
Systematic analyses of epidemiological studies on the effects
of olive oil on cancer development indicated decreased rela-
tive risks or odds ratios for breast cancer, cancers of the diges-
tive system, or neoplasms of the respiratory tract [92]. Extra-
virgin olive oil is rich in both monounsaturated fatty acids and
in polyphenolic compounds such as tyrosol, hydroxytyrosol,
and oleuropein. It has been speculated that the phenolic con-
tent of extra virgin and virgin olive oil is able to specifically
affect cancer-regulated oncogenes [96–98]. Furthermore, they
may exert strong chemo-preventive effects via a variety of
distinct mechanisms, including both direct anti-oxidant effects
and actions on cancer cell signaling and cell cycle progression
[99].
Alcohol and Red Wine in Moderate Amounts
Moderate consumption of alcohol in a MD is usually charac-
terized by a threshold of <30 g ethanol/day for men and less
than 20 g/day for women with a focus on red wine containing
secondary plant substances such as polyphenols. These light
amounts of alcohol were found to be associatedwith a reduced
risk of cardiovascular disease in a number of observational
studies. On the other hand, alcoholic beverages providing
≥30 g ethanol/day are associated with increased risks of dif-
ferent cancers (e.g., cancers of the pharynx, larynx, esopha-
gus, colorectum, breast, and liver) [100]. The effects of light
alcohol drinking on cancer development and progression are
still discussed controversially. While moderate consumption
of less than 12.5 g ethanol/day was found to correlate with a
decreased risk of cancer mortality when compared to non-
drinkers [101•], the same amount of alcohol was reported to
increase the risk of cancer for various locations in a meta-
analysis by Bagnardi et al. [102].
Red and Processed Meat
Within the context of a MD, red and processed meat (and
sometimes poultry) are regarded to be unfavorable com-
pounds which should be consumed in low amounts. There is
considerable evidence derived from meta-analyses linking
high consumption of meat and/or processed meat with an
increased risk of cancer mortality [103]. In addition, a meta-
analysis of 21 observational studies presented by Xu et al.
demonstrated that high consumption of red meat/processed
meat is associated with an increased risk of colorectal adeno-
mas [104].
Dairy Products
Different and sometimes contradictory results are reported
with respect to consumption of milk and dairy products and
the risk of cancer. In a recent report of two independent
Swedish cohort studies, Michaelsson and co-workers [105]
could demonstrate an increased adjusted hazard ratio for each
glass of milk with respect to death caused by cancer in a
female cohort. On the other hand, meta-analyzing the data
available from cohort studies does not confirm a detrimental
effect of dairy products. In contrast, milk and dairy product
consumption was associated with a decreased relative risk for
development of colorectal cancer [106], and total dairy food
intake was found to be associated with a decreased risk of
breast cancer [107].
Conclusion
It was the aim of the present review to summarize
evidence provided by randomized and observational stud-
ies on the potential effects of a Mediterranean diet on
cancer development, progression, and mortality. The data
support the concept that a MD has a benefit with respect
to these clinical outcomes, i.e., adherence to a MD was
associated with reduced risk of overall cancer mortality as
well as incidence of colorectal, breast, gastric, prostate,
liver, and head and neck cancer. When dismantling the
Mediterranean diet into its components, it seems that there
is no single ingredient or food category mediating these
favorable effects. It seems instead to be the result of the
complex food pattern characteristic for a MD. However,
one should keep in mind the limitations of and differences
between the underlying studies. Apart from the problems
stemming from the design of observational studies in gen-
eral, a strong methodological issue is the wide variety of
scores used to identify adherence to a MD. Nevertheless,
taking into account the increasing number of observations
reporting a beneficial effect of a Mediterranean diet in the
primary and secondary prevention of other chronic
diseases as well, it does not seem reasonable to exclude
an MD pattern from dietary recommendations aimed at
cancer prevention.
Compliance with Ethics Guidelines
Conflict of Interest Lukas Schwingshackl and Georg
Hoffmann declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent This
article does not contain any studies with human or animal
subjects performed by any of the authors.
Curr Nutr Rep (2016) 5:9–17 13
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
Papers of particular interest, published recently, have been
highlighted as:
• Of importance
•• Of major importance
1. Mortality GBD, Causes of Death C. Global, regional, and national
age-sex specific all-cause and cause-specific mortality for 240
causes of death, 1990-2013: a systematic analysis for the Global
Burden of Disease Study 2013. Lancet. 2014. doi:10.1016/S0140-
6736(14)61682-2.
2. Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer
prevalence for 27 sites in the adult population in 2008. Int J
Cancer. 2013;132(5):1133–45. doi:10.1002/ijc.27711.
3. Trichopoulou A, Lagiou P, Kuper H, Trichopoulos D. Cancer and
Mediterranean dietary traditions. Cancer Epidemiol Biomark
Prev. 2000;9(9):869–73.
4. Willett WC, Sacks F, TrichopoulouA, Drescher G, Ferro-Luzzi A,
Helsing E, et al. Mediterranean diet pyramid: a cultural model for
healthy eating. Am J Clin Nutr. 1995;61(6 Suppl):1402S–6S.
5.• Schwingshackl L, Hoffmann G. Mediterranean dietary pattern,
inflammation and endothelial function: a systematic review and
meta-analysis of intervention trials. Nutrition, metabolism, and
cardiovascular diseases. NMCD. 2014;24(9):929–39. doi:10.
1016/j.numecd.2014.03.003. The present meta-analysis of 17
intervention trials showed that following aMediterranean diet
was associated with impovements in markers of endothelial
function and inflammation.
6. Singh B, Parsaik AK, Mielke MM, Erwin PJ, Knopman DS,
Petersen RC, et al. Association of Mediterranean diet with mild
cognitive impairment and Alzheimer’s disease: a systematic re-
view and meta-analysis. J Alzheimers Dis: JAD. 2014;39(2):
271–82. doi:10.3233/JAD-130830.
7. Schwingshackl L, Missbach B, Konig J, Hoffmann G. Adherence
to a Mediterranean diet and risk of diabetes: a systematic review
and meta-analysis. Public Health Nutr. 2015;18(7):1292–9. doi:
10.1017/S1368980014001542.
8. Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on
benefits of adherence to the Mediterranean diet on health: an up-
dated systematic review and meta-analysis. Am J Clin Nutr.
2010;92(5):1189–96. doi:10.3945/ajcn.2010.29673.
9. Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Adherence to
Mediterranean diet and health status: meta-analysis. BMJ.
2008;337:a1344. doi:10.1136/bmj.a1344.
10.•• Schwingshackl L, Hoffmann G. Adherence to Mediterranean diet
and risk of cancer: a systematic review and meta-analysis of ob-
servational studies. Int J Cancer Int J Cancer. 2014;135(8):1884–
97. doi:10.1002/ijc.28824. In this comprehensive meta-analysis
of 1,4 million subjects, high adherence to aMediterranean diet
was associated with a significant reduction in the risk of sev-
eral types of cancer, especially colorectal and aerodigestive
tract cancers.
11.•• Schwingshackl L, Hoffmann G. Adherence to Mediterranean diet
and risk of cancer: an updated systematic review and meta-
analysis of observational studies. Cancer Med (accepted). 2015.
This updated meta-analysis of 56 observational studies con-
firmed a prominent and consistent inverse association provid-
ed by adherence to a Mediterranean Diet in relation to cancer
mortality (10% reduced risk) and risk (only incidence) of sev-
eral cancer types (colorectal, breast, liver, gastric, prostate,
head and neck, pancreatic, and respiratory tract cancers).
12. DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer
JL, et al. Cancer treatment and survivorship statistics, 2014. CA
Cancer J Clin. 2014;64(4):252–71. doi:10.3322/caac.21235.
13. Rowland JH, Kent EE, Forsythe LP, Loge JH, Hjorth L, Glaser A,
et al. Cancer survivorship research in Europe and the United
States: where have we been, where are we going, and what can
we learn from each other? Cancer. 2013;119 Suppl 11:2094–108.
doi:10.1002/cncr.28060.
14.• Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J,
Courneya KS, Schwartz AL, et al. Nutrition and physical activity
guidelines for cancer survivors. CA Cancer J Clin. 2012;62(4):
243–74. doi:10.3322/caac.21142. This report summarizes the
current findings regardings lifeytle factors including
nutrition and physical activity.
15. Jones LW, Demark-Wahnefried W. Diet, exercise, and comple-
mentary therapies after primary treatment for cancer. Lancet
Oncol. 2006;7(12):1017–26. doi:10.1016/S1470-2045(06)
70976-7.
16. Trichopoulou A, Kouris-Blazos A, Wahlqvist ML, Gnardellis C,
Lagiou P, Polychronopoulos E, et al. Diet and overall survival in
elderly people. BMJ. 1995;311(7018):1457–60.
17. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D.
Adherence to a Mediterranean diet and survival in a Greek popu-
lation. N Engl J Med. 2003;348(26):2599–608. doi:10.1056/
NEJMoa025039.
18. Fung TT, Hu FB, McCullough ML, Newby PK, Willett WC,
Holmes MD. Diet quality is associated with the risk of estrogen
receptor-negative breast cancer in postmenopausal women. J Nutr.
2006;136(2):466–72.
19. Whalen KA, McCullough M, Flanders WD, Hartman TJ, Judd S,
Bostick RM. Paleolithic andMediterranean diet pattern scores and
risk of incident, sporadic colorectal adenomas. Am J Epidemiol.
2014;180(11):1088–97. doi:10.1093/aje/kwu235.
20. Tognon G, Nilsson LM, Lissner L, Johansson I, Hallmans G,
Lindahl B, et al. The Mediterranean diet score and mortality are
inversely associated in adults living in the subarctic region. J Nutr.
2012;142(8):1547–53. doi:10.3945/jn.112.160499.
21. Xie J, Poole EM, Terry KL, Fung TT, Rosner BA, Willett WC,
et al. A prospective cohort study of dietary indices and incidence
of epithelial ovarian cancer. J Ovarian Res. 2014;7(1):112. doi:10.
1186/s13048-014-0112-4.
22. Panagiotakos DB, Pitsavos C, Arvaniti F, Stefanadis C.
Adherence to the Mediterranean food pattern predicts the preva-
lence of hypertension, hypercholesterolemia, diabetes and obesi-
ty, among healthy adults; the accuracy of the MedDietScore. Prev
Med. 2007;44(4):335–40. doi:10.1016/j.ypmed.2006.12.009.
23. Panagiotakos DB, Pitsavos C, Stefanadis C. Dietary patterns: a
Mediterranean diet score and its relation to clinical and biological
markers of cardiovascular disease risk. Nutr Metab Cardiovasc
Dis: NMCD. 2006;16(8):559–68. doi:10.1016/j.numecd.2005.
08.006.
24. Gerber M. Qualitative methods to evaluate Mediterranean diet in
adults. Public Health Nutr. 2006;9(1A):147–51.
25. Goulet J, Lamarche B, Nadeau G, Lemieux S. Effect of a nutri-
tional intervention promoting the Mediterranean food pattern on
plasma lipids, lipoproteins and body weight in healthy French-
Canadian women. Atherosclerosis. 2003;170(1):115–24.
26. Ciccarone E, Di Castelnuovo A, Salcuni M, Siani A, Giacco A,
Donati MB, et al. A high-score Mediterranean dietary pattern is
14 Curr Nutr Rep (2016) 5:9–17
associated with a reduced risk of peripheral arterial disease in
Italian patients with Type 2 diabetes. J Thromb Haemost.
2003;1(8):1744–52. doi:10.1046/j.1538-7836.2003.00323.x.
27. Sánchez-Villegas A, Martínez JA, De Irala J, Martínez-González
MA. Determinants of the adherence to an Ba priori^ defined
Mediterranean dietary pattern. Eur J Nutr. 2002;41(6):249–57.
doi:10.1007/s00394-002-0382-2.
28. Alberti-Fidanza A, Fidanza F, Chiuchiu MP, Verducci G, Fruttini
D. Dietary studies on two rural italian population groups of the
Seven Countries Study. 3. Trend Of food and nutrient intake from
1960 to 1991. Eur J Clin Nutr. 1999;53(11):854–60.
29. de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL,
Monjaud I, et al. Mediterranean alpha-linolenic acid-rich diet in
secondary prevention of coronary heart disease. Lancet.
1994;343(8911):1454–9.
30.•• Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F,
et al. Primary prevention of cardiovascular disease with a
Mediterranean diet. N Engl J Med. 2013;368(14):1279–90. doi:
10.1056/NEJMoa1200303. The PREDIMED study is the
largest randomized controlled trial to date showing a
reduced risk of cardiovascular disease following a
Mediterranean Diet rich in extra virgin olive oil or nuts
compared to a low fat diet.
31.• Guasch-Ferre M, Bullo M, Martinez-Gonzalez MA, Ros E,
Corella D, Estruch R, et al. Frequency of nut consumption and
mortality risk in the PREDIMED nutrition intervention trial. BMC
Med. 2013;11:164. doi:10.1186/1741-7015-11-164. The results
of the largest MD trial, the PREDIMED study including 7447
subjects, showed that the highest category of nuts intake (>3
servings/week) was associated with a 40% risk reduction of
cancer mortality when compared to the lowest category,
whereas the differences observed between consumers of
extra virgin olive oil did not attain statistical significance.
32.• Guasch-Ferre M, Hu FB, Martinez-Gonzalez MA, Fito M, Bullo
M, Estruch R, et al. Olive oil intake and risk of cardiovascular
disease and mortality in the PREDIMED Study. BMC Med.
2014;12(1):78. doi:10.1186/1741-7015-12-78. The results of
the largest MD trial, the PREDIMED study including 7447
subjects, showed that the highest category of nuts intake (>3
servings/week) was associated with a 40% risk reduction of
cancer mortality when compared to the lowest category,
whereas the differences observed between consumers of
extra virgin olive oil did not attain statistical significance.
33. Buckland G, Agudo A, Travier N, Huerta JM, Cirera L, Tormo
MJ, et al. Adherence to theMediterranean diet reduces mortality in
the Spanish cohort of the European Prospective Investigation into
Cancer and Nutrition (EPIC-Spain). Br J Nutr. 2011;106(10):
1581–91. doi:10.1017/S0007114511002078.
34. Knoops KT, de Groot LC, Kromhout D, Perrin AE, Moreiras-
Varela O, Menotti A, et al. Mediterranean diet, lifestyle factors,
and 10-year mortality in elderly European men and women: the
HALE project. JAMA. 2004;292(12):1433–9. doi:10.1001/jama.
292.12.1433.
35. Lagiou P, Trichopoulos D, Sandin S, Lagiou A, Mucci L, Wolk A,
et al. Mediterranean dietary pattern and mortality among young
women: a cohort study in Sweden. Br J Nutr. 2006;96(2):384–92.
36. Martinez-Gonzalez MA, Guillen-Grima F, De Irala J, Ruiz-Canela
M, Bes-Rastrollo M, Beunza JJ, et al. The Mediterranean diet is
associated with a reduction in premature mortality among middle-
aged adults. J Nutr. 2012;142(9):1672–8. doi:10.3945/jn.112.
162891.
37. Menotti A, Alberti-Fidanza A, Fidanza F, Lanti M, Fruttini D.
Factor analysis in the identification of dietary patterns and their
predictive role in morbid and fatal events. Public Health Nutr.
2012;15(7):1232–9. doi:10.1017/S1368980011003235.
38. Harmon BE, Boushey CJ, Shvetsov YB, Ettienne R, Reedy J,
Wilkens LR, et al. Associations of key diet-quality indexes with
mortality in the Multiethnic Cohort: the Dietary Patterns Methods
Project. Am J Clin Nutr. 2015;101(3):587–97. doi:10.3945/ajcn.
114.090688.
39. Lopez-Garcia E, Rodriguez-Artalejo F, Li TY, Fung TT, Li S,
Willett WC, et al. The Mediterranean-style dietary pattern and
mortality among men and women with cardiovascular disease.
Am J Clin Nutr. 2014;99(1):172–80. doi:10.3945/ajcn.113.
068106.
40. George SM, Ballard-Barbash R, Manson JE, Reedy J, Shikany
JM, Subar AF, et al. Comparing indices of diet quality with chron-
ic disease mortality risk in postmenopausal women in the
Women’s Health Initiative Observational Study: evidence to in-
form national dietary guidance. Am J Epidemiol. 2014;180(6):
616–25. doi:10.1093/aje/kwu173.
41. Vormund K, Braun J, Rohrmann S, Bopp M, Ballmer P, Faeh D.
Mediterranean diet and mortality in Switzerland: an alpine para-
dox? Eur J Nutr. 2015;54(1):139–48. doi:10.1007/s00394-014-
0695-y.
42. Reedy J, Krebs-Smith SM, Miller PE, Liese AD, Kahle LL, Park
Y, et al. Higher diet quality is associated with decreased risk of all-
cause, cardiovascular disease, and cancer mortality among older
adults. J Nutr. 2014. doi:10.3945/jn.113.189407.
43. Buckland G, Travier N, Cottet V, Gonzalez CA, Lujan-Barroso L,
Agudo A, et al. Adherence to the mediterranean diet and risk of
breast cancer in the European prospective investigation into cancer
and nutrition cohort study. Int J Cancer Int J Cancer.
2013;132(12):2918–27. doi:10.1002/ijc.27958.
44. Cade JE, Taylor EF, Burley VJ, Greenwood DC. Does the
Mediterranean dietary pattern or the Healthy Diet Index influence
the risk of breast cancer in a large British cohort of women? Eur J
Clin Nutr. 2011;65(8):920–8. doi:10.1038/ejcn.2011.69.
45. Couto E, Sandin S, Lof M, Ursin G, Adami HO, Weiderpass E.
Mediterranean dietary pattern and risk of breast cancer. PLoSOne.
2013;8(2):e55374. doi:10.1371/journal.pone.0055374.
46. Bessaoud F, Tretarre B, Daures JP, Gerber M. Identification of
dietary patterns using two statistical approaches and their associ-
ation with breast cancer risk: a case-control study in Southern
France. Ann Epidemiol. 2012;22(7):499–510. doi:10.1016/j.
annepidem.2012.04.006.
47. Castello A, Pollan M, Buijsse B, Ruiz A, Casas AM, Baena-
Canada JM, et al. Spanish Mediterranean diet and other dietary
patterns and breast cancer risk: case-control EpiGEICAM study.
Br J Cancer. 2014;111(7):1454–62. doi:10.1038/bjc.2014.434.
48. Demetriou CA, Hadjisavvas A, Loizidou MA, Loucaides G,
Neophytou I, Sieri S, et al. The mediterranean dietary pattern
and breast cancer risk in Greek-Cypriot women: a case-control
study. BMC Cancer. 2012;12:113. doi:10.1186/1471-2407-12-
113.
49. Mourouti N, Kontogianni MD, Papavagelis C, Plytzanopoulou P,
Vassilakou T, Malamos N, et al. Adherence to the Mediterranean
diet is associated with lower likelihood of breast cancer: a case-
control study. Nutr Cancer. 2014;66(5):810–7. doi:10.1080/
01635581.2014.916319.
50. Murtaugh MA, Sweeney C, Giuliano AR, Herrick JS, Hines L,
Byers T, et al. Diet patterns and breast cancer risk in Hispanic and
non-Hispanic white women: the Four-Corners Breast Cancer
Study. Am J Clin Nutr. 2008;87(4):978–84.
51. Nkondjock A, Ghadirian P. Diet quality and BRCA-associated
breast cancer risk. Breast Cancer Res Treat. 2007;103(3):361–9.
doi:10.1007/s10549-006-9371-0.
52. Wu AH, Yu MC, Tseng CC, Stanczyk FZ, Pike MC. Dietary
patterns and breast cancer risk in Asian American women. Am J
Clin Nutr. 2009;89(4):1145–54. doi:10.3945/ajcn.2008.26915.
Curr Nutr Rep (2016) 5:9–17 15
53. Pot GK, Stephen AM, Dahm CC, Key TJ, Cairns BJ, Burley VJ,
et al. Dietary patterns derived with multiple methods from food
diaries and breast cancer risk in the UK Dietary Cohort
Consortium. Eur J Clin Nutr. 2014;68(12):1353–8. doi:10.1038/
ejcn.2014.135.
54. Bamia C, Lagiou P, Buckland G, Grioni S, Agnoli C, Taylor AJ,
et al. Mediterranean diet and colorectal cancer risk: results from a
European cohort. Eur J Epidemiol. 2013;28(4):317–28. doi:10.
1007/s10654-013-9795-x.
55. Fung TT, McCullough ML, Newby PK, Manson JE, Meigs JB,
Rifai N, et al. Diet-quality scores and plasma concentrations of
markers of inflammation and endothelial dysfunction. Am J Clin
Nutr. 2005;82(1):163–73.
56. Reedy J, Mitrou PN, Krebs-Smith SM,Wirfalt E, Flood A, Kipnis
V, et al. Index-based dietary patterns and risk of colorectal cancer:
the NIH-AARP Diet and Health Study. Am J Epidemiol.
2008;168(1):38–48. doi:10.1093/aje/kwn097.
57. Dixon LB, Subar AF, Peters U, Weissfeld JL, Bresalier RS, Risch
A, et al. Adherence to the USDA Food Guide, DASH Eating Plan,
and Mediterranean dietary pattern reduces risk of colorectal ade-
noma. J Nutr. 2007;137(11):2443–50.
58. Grosso G, Biondi A, Galvano F, Mistretta A, Marventano S,
Buscemi S, et al. Factors associated with colorectal cancer in the
context of the Mediterranean diet: a case-control study. Nutr
Cancer. 2014;66(4):558–65. doi:10.1080/01635581.2014.
902975.
59. Kontou N, Psaltopoulou T, Soupos N, Polychronopoulos E,
Xinopoulos D, Linos A, et al. Metabolic syndrome and colorectal
cancer: the protective role of Mediterranean diet–a case-control
s tudy. Angiology. 2012;63(5) :390–6. doi :10.1177/
0003319711421164.
60. Ax E, Garmo H, Grundmark B, Bill-Axelson A, Holmberg L,
Becker W, et al. Dietary patterns and prostate cancer risk: report
from the population based ULSAM cohort study of Swedish men.
Nutr Cancer. 2014;66(1):77–87. doi:10.1080/01635581.2014.
851712.
61. Bosire C, Stampfer MJ, Subar AF, Park Y, Kirkpatrick SI, Chiuve
SE, et al. Index-based dietary patterns and the risk of prostate
cancer in the NIH-AARP diet and health study. Am J Epidemiol.
2013;177(6):504–13. doi:10.1093/aje/kws261.
62. Kenfield SA, Dupre N, Richman EL, Stampfer MJ, Chan JM,
Giovannucci EL. Mediterranean Diet and Prostate Cancer Risk
and Mortality in the Health Professionals Follow-up Study. Eur
Urol. 2013. doi:10.1016/j.eururo.2013.08.009.
63. Möller E, Galeone C, Andersson T, Bellocco R, Adami HO,
Andrén O, et al. Mediterranean Diet Score and prostate cancer
risk in a Swedish population-based case-control study. J Nutr
Sci. 2013;2:1–13.
64. Buckland G, Agudo A, Lujan L, Jakszyn P, Bueno-de-Mesquita
HB, Palli D, et al. Adherence to a Mediterranean diet and risk of
gastric adenocarcinoma within the European Prospective
Investigation into Cancer and Nutrition (EPIC) cohort study. Am
J Clin Nutr. 2010;91(2):381–90. doi:10.3945/ajcn.2009.28209.
65.• Li WQ, Park Y, Wu JW, Ren JS, Goldstein AM, Taylor PR, et al.
Index-based Dietary Patterns and Risk of Esophageal and Gastric
Cancer in a Large Cohort Study. Clin Gastroenterol Hepatol.
2013;11(9):1130–6. doi:10.1016/j.cgh.2013.03.023. Data from
the National Institutes of Health-AARP Diet and Health
Study indicate that high adherence to Mediterranean diet
was inveresely associated with risk for esophageal cancers,
particularly esophageal squamous cell carcinoma.
66. Praud D, Bertuccio P, Bosetti C, Turati F, Ferraroni M, La Vecchia
C. Adherence to the Mediterranean diet and gastric cancer risk in
Italy. Int J Cancer Int J Cancer. 2014;134(12):2935–41. doi:10.
1002/ijc.28620.
67. Li WQ, Park Y, McGlynn KA, Hollenbeck AR, Taylor PR,
Goldstein AM, et al. Index-based dietary patterns and risk of in-
cident hepatocellular carcinoma and mortality from chronic liver
disease in a prospective study. Hepatology. 2014. doi:10.1002/
hep.27160.
68. Turati F, Trichopoulos D, Polesel J, Bravi F, Rossi M, Talamini R,
et al. Mediterranean diet and hepatocellular carcinoma. J Hepatol.
2014;60(3):606–11. doi:10.1016/j.jhep.2013.10.034.
69. Bosetti C, Gallus S, Trichopoulou A, Talamini R, Franceschi S,
Negri E, et al. Influence of the Mediterranean diet on the risk of
cancers of the upper aerodigestive tract. Cancer Epidemiol
Biomark Prev: Publ Am Assoc Cancer Res Cosponsored Am
Soc Prev Oncol. 2003;12(10):1091–4.
70. Li WQ, Park Y, Wu JW, Goldstein AM, Taylor PR, Hollenbeck
AR, et al. Index-based dietary patterns and risk of head and neck
cancer in a large prospective study. Am J Clin Nutr. 2014. doi:10.
3945/ajcn.113.073163.
71. Filomeno M, Bosetti C, GaravelloW, Levi F, Galeone C, Negri E,
et al. The role of a Mediterranean diet on the risk of oral and
pharyngeal cancer. Br J Cancer. 2014;111(5):981–6. doi:10.
1038/bjc.2014.329.
72. Samoli E, LagiouA,Nikolopoulos E, Lagogiannis G, Barbouni A,
Lefantzis D, et al. Mediterranean diet and upper aerodigestive tract
cancer: the Greek segment of the Alcohol-Related Cancers and
Genetic Susceptibility in Europe study. Br J Nutr. 2010;104(9):
1369–74. doi:10.1017/S0007114510002205.
73. Bosetti C, Turati F, Pont AD, FerraroniM, Polesel J, Negri E, et al.
The role of Mediterranean diet on the risk of pancreatic cancer. Br
J Cancer. 2013;109(5):1360–6. doi:10.1038/bjc.2013.345.
74. Buckland G, Ros MM, Roswall N, Bueno-de-Mesquita HB,
Travier N, Tjonneland A, et al. Adherence to the Mediterranean
diet and risk of bladder cancer in the EPIC cohort study. Int J
Cancer Int J Cancer. 2014;134(10):2504–11. doi:10.1002/ijc.
28573.
75. George SM, Ballard-Barbash R, Shikany JM, Crane TE,
Neuhouser ML. A prospective analysis of diet quality and endo-
metrial cancer among 84,415 postmenopausal women in The
Women’s Health Initiative. Ann Epidemiol. 2015;25(10):788–93
doi:10.1016/j.annepidem.2015.05.009.
76. FilomenoM, Bosetti C, Bidoli E, Levi F, Serraino D, Montella M,
et al. Mediterranean diet and risk of endometrial cancer: a pooled
analysis of three italian case-control studies. Br J Cancer.
2015;112(11):1816–21. doi:10.1038/bjc.2015.153.
77. Dalvi TB, Canchola AJ, Horn-Ross PL. Dietary patterns,
Mediterranean diet, and endometrial cancer risk. Cancer Causes
Control: CCC. 2007;18(9):957–66. doi:10.1007/s10552-007-
9037-1.
78. Gnagnarella P, Maisonneuve P, Bellomi M, Rampinelli C,
Bertolotti R, Spaggiari L, et al. Red meat, Mediterranean diet
and lung cancer risk among heavy smokers in the COSMOS
screening study. Ann Oncol: Off J Eur Soc Med Oncol / ESMO.
2013;24(10):2606–11. doi:10.1093/annonc/mdt302.
79.• Fung TT, Kashambwa R, Sato K, Chiuve SE, Fuchs CS, Wu K,
et al. Post diagnosis diet quality and colorectal cancer survival in
women. PLoS One. 2014;9(12):e115377. doi:10.1371/journal.
pone.0115377. Higher adhernce to Mediterranean diet was
not associated with reduced risk of colorectal cancer or
overall mortality in the Nurses Health Study among
colorectal cancer survivors.
80. KimEH,WillettWC, Fung T, Rosner B, HolmesMD. Diet quality
indices and postmenopausal breast cancer survival. Nutr Cancer.
2011;63(3):381–8. doi:10.1080/01635581.2011.535963.
81. Cottet V, Bonithon-Kopp C, Kronborg O, Santos L, Andreatta R,
Boutron-Ruault MC, et al. Dietary patterns and the risk of colo-
rectal adenoma recurrence in a European intervention trial. Eur J
16 Curr Nutr Rep (2016) 5:9–17
Cancer Prev: Off J Eur Cancer Prev Organ (ECP). 2005;14(1):21–
9.
82. Kroenke CH, Fung TT, Hu FB, Holmes MD. Dietary patterns and
survival after breast cancer diagnosis. J Clin Oncol: Off J Am Soc
Clin Oncol. 2005;23(36):9295–303. doi:10.1200/JCO.2005.02.
0198.
83. Kwan ML, Weltzien E, Kushi LH, Castillo A, Slattery ML, Caan
BJ. Dietary patterns and breast cancer recurrence and survival
among women with early-stage breast cancer. J Clin Oncol: Off
J Am Soc Clin Oncol. 2009;27(6):919–26. doi:10.1200/JCO.
2008.19.4035.
84. Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Hu FB,
Mayer RJ, et al. Association of dietary patterns with cancer recur-
rence and survival in patients with stage III colon cancer. JAMA.
2007;298(7):754–64. doi:10.1001/jama.298.7.754.
85. Arts IC, Hollman PC. Polyphenols and disease risk in epidemio-
logic studies. Am J Clin Nutr. 2005;81(1 Suppl):317S–25S.
86. Benetou V, Orfanos P, Lagiou P, Trichopoulos D, Boffetta P,
Trichopoulou A. Vegetables and fruits in relation to cancer risk:
evidence from the Greek EPIC cohort study. Cancer Epidemiol
Biomark Prev: Publ Am Assoc Cancer Res Cosponsored Am Soc
Prev Oncol. 2008;17(2):387–92. doi:10.1158/1055-9965.epi-07-
2665.
87. Boffetta P, Couto E, Wichmann J, Ferrari P, Trichopoulos D,
Bueno-de-Mesquita HB, et al. Fruit and vegetable intake and over-
all cancer risk in the European Prospective Investigation into
Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2010;102(8):
529–37. doi:10.1093/jnci/djq072.
88. George SM, Park Y, Leitzmann MF, Freedman ND, Dowling EC,
Reedy J, et al. Fruit and vegetable intake and risk of cancer: a
prospective cohort study. Am J Clin Nutr. 2009;89(1):347–53.
doi:10.3945/ajcn.2008.26722.
89.• Zheng J-S, Hu X-J, Zhao Y-M, Yang J, Li D. Intake of fish and
marine n-3 polyunsaturated fatty acids and risk of breast cancer:
meta-analysis of data from 21 independent prospective cohort
studies. 2013; 346. doi:10.1136/bmj.f3706. This meta-analysis
showed that higher consumption of dietary marine n-3
PUFA is associated with a lower risk of breast cancer.
90. Han YJ, Li J, Huang W, Fang Y, Xiao LN, Liao ZE. Fish con-
sumption and risk of esophageal cancer and its subtypes: a sys-
tematic review and meta-analysis of observational studies. Eur J
Clin Nutr. 2013;67(2):147–54. doi:10.1038/ejcn.2012.213.
91. Williams MT, Hord NG. The role of dietary factors in cancer
prevention: beyond fruits and vegetables. Nutr Clin Pract: Off
Publ Am Soc Parenter Enter Nutr. 2005;20(4):451–9.
92. Haas P, Machado MJ, Anton AA, Silva ASS, de Francisco A.
Effectiveness of whole grain consumption in the prevention of
colorectal cancer: Meta-analysis of cohort studies. Int J Food Sci
Nutr. 2009;60(s6):1–13. doi:10.1080/09637480802183380.
93. Aune D, ChanDS, LauR,Vieira R, GreenwoodDC, KampmanE,
et al. Dietary fibre, whole grains, and risk of colorectal cancer:
systematic review and dose-response meta-analysis of prospective
studies. BMJ. 2011;343:d6617. doi:10.1136/bmj.d6617.
94. Pereira MA, Jacobs DR, Pins JJ, Raatz SK, Gross MD, Slavin JL,
et al. Effect of whole grains on insulin sensitivity in overweight
hyperinsulinemic adults. Am J Clin Nutr. 2002;75(5):848–55.
95. Weickert MO, Pfeiffer AFH. Metabolic effects of dietary fiber
consumption and prevention of diabetes. J Nutr. 2008;138(3):
439–42.
96. Sotiroudis TG, Kyrtopoulos SA. Anticarcinogenic compounds of
olive oil and related biomarkers. Eur J Nutr. 2008;47 Suppl 2:69–
72. doi:10.1007/s00394-008-2008-9.
97. Schwingshackl L, Hoffmann G. Monounsaturated fatty acids, ol-
ive oil and health status: a systematic review and meta-analysis of
cohort studies. Lipids Health Dis. 2014;13:154. doi:10.1186/
1476-511X-13-154.
98. Schwingshackl L, Hoffmann G. Association of dietary, circulat-
ing, and supplement fatty acids with coronary risk. Ann Intern
Med. 2014;161(6):455–6. doi:10.7326/L14-5018-6.
99. Corona G, Spencer JP, Dessi MA. Extra virgin olive oil phenolics:
absorption, metabolism, and biological activities in the GI tract.
Toxicol Ind Health. 2009;25(4-5):285–93. doi:10.1177/
0748233709102951.
100. World Cancer Research Fund / American Institute for Cancer
Research. Food, Nutrition, Physical Activity, and the Prevention
of Cancer: a Global Perspective. Washington DC: AICR; 2007.
101.• JinM, Cai S, Guo J, Zhu Y, LiM, YuY, et al. Alcohol drinking and
all cancer mortality: a meta-analysis. Ann Oncol. 2013;24(3):807–
16. doi:10.1093/annonc/mds508. This meta-analysis of eighteen
cohort studies indicated that light drinkers (≤12.5 g/day) had a
9% lower risk of cancer mortality compared with non/
occasional drinkers, whereas heavy drinkers (≥50g/d) had a
31% increased risk.
102. Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V,
et al. Light alcohol drinking and cancer: a meta-analysis. Ann
Oncol. 2013;24(2):301–8. doi:10.1093/annonc/mds337.
103. O’Sullivan TA, Hafekost K, Mitrou F, Lawrence D. Food sources
of saturated fat and the association with mortality: a meta-analysis.
Am J Public Health. 2013;103(9):e31–42. doi:10.2105/AJPH.
2013.301492.
104. Xu X, Yu E, Gao X, Song N, Liu L, Wei X, et al. Red and proc-
essedmeat intake and risk of colorectal adenomas: a meta-analysis
of observational studies. Int J Cancer Int J Cancer. 2013;132(2):
437–48. doi:10.1002/ijc.27625.
105. Michaëlsson K, Wolk A, Langenskiöld S, Basu S, Warensjö
Lemming E, Melhus H, Byberg L. Milk intake and risk of mor-
tality and fractures in women and men: cohort studies. 2014; 349.
doi:10.1136/bmj.g6015.
106. AuneD, Lau R, ChanDS, Vieira R, GreenwoodDC, Kampman E,
et al. Dairy products and colorectal cancer risk: a systematic re-
view and meta-analysis of cohort studies. Ann Oncol: Off J Eur
Soc Med Oncol / ESMO. 2012;23(1):37–45. doi:10.1093/annonc/
mdr269.
107. Dong JY, Zhang L, He K, Qin LQ. Dairy consumption and risk of
breast cancer: a meta-analysis of prospective cohort studies. Breast
Cancer Res Treat. 2011;127(1):23–31. doi:10.1007/s10549-011-
1467-5.
Curr Nutr Rep (2016) 5:9–17 17
